Prince Pharmaceutical Co., Ltd. (TPEX:6935)
Taiwan
· Delayed Price · Currency is TWD 27.55
-1.00 (-3.50%)
Mar 9, 2026, 12:31 PM CST
Prince Pharmaceutical Market Cap
Prince Pharmaceutical has a market cap or net worth of 1.01 billion as of March 9, 2026. Its market cap has increased by 20.09% in one year.
Market Cap
1.01B
Enterprise Value
1.37B
Revenue
798.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
27.55
Market Cap Chart
Since March 29, 2023, Prince Pharmaceutical's market cap has decreased from 1.94B to 1.01B, a decrease of -48.21%. That is a compound annual growth rate of -20.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.05B | -8.20% |
| Dec 31, 2025 | 1.14B | 42.01% |
| Dec 31, 2024 | 801.65M | -36.72% |
| Dec 29, 2023 | 1.27B | -34.82% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mediera | 1.06B |
| Original BioMedicals | 1.11B |
| Anxo Pharmaceutical | 1.13B |
| Excelsior Biopharma | 1.26B |
| DV Biomed | 1.34B |
| Winston Medical Supply | 1.48B |
| Bioray Biotech | 710.05M |
| General Biologicals | 678.20M |